Pegylated recombinant human granulocyte colony-stimulating factor enhances radiotherapy completion and safety in concurrent chemoradiotherapy for cervical cancer: a retrospective analysis
This study explores the application of PEG-rhG-CSF in concurrent chemoradiotherapy for cervical cancer. A retrospective analysis evaluates its effectiveness in helping patients' complete radiotherapy on time, reducing hematologic toxicity, and ensuring safety.
Authors
- Xin Wen (ORCID: https://orcid.org/0000-0001-8904-1340)
- Xuejiao Xing
- Gaoli Niu
- Luhong Meng
- Nannan Liu (ORCID: https://orcid.org/0009-0006-8202-367X)
- Yanhong Zhai (ORCID: https://orcid.org/0000-0003-3412-299X)
- Lingli Zhao (ORCID: https://orcid.org/0000-0002-2399-2503)
- Yajuan Ren
Institutions
- Henan Polytechnic University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-04
- DOI
- https://doi.org/10.3389/fonc.2025.1640418
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Henan Polytechnic University